1tsd: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1tsd.gif|left|200px]]
{{Seed}}
[[Image:1tsd.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1tsd|  PDB=1tsd  |  SCENE=  }}  
{{STRUCTURE_1tsd|  PDB=1tsd  |  SCENE=  }}  


'''THYMIDYLATE SYNTHASE COMPLEX WITH 2'-DEOXYURIDINE 5'-MONOPHOSPHATE (DUMP) AND FOLATE ANALOG 1843U89'''
===THYMIDYLATE SYNTHASE COMPLEX WITH 2'-DEOXYURIDINE 5'-MONOPHOSPHATE (DUMP) AND FOLATE ANALOG 1843U89===




==Overview==
<!--
The anticancer drug 1843U89 inhibits thymidylate synthase (TS) at sub-nanomolar concentrations and is undergoing clinical trial. The 1.95 A crystal structure of Escherichia coli TS bound to the drug and dUMP reveals that the 1843U89 binding surface includes a hydrophobic patch that is normally buried. To reach this patch, 1843U89 inserts into the wall of the TS active site, resulting in a severe local distortion of the protein. In this new conformation, active-site groups that normally bind to the catalytic cofactor methylene-tetrahydrofolate instead bind to 1843U89 in new ways. This structure provides a rare example of a protein that can bind tightly to distinct substances using a single, flexible, binding surface. This has implications for drug design, as 1843U89 could not have been obtained from current structure-based approaches.
The line below this paragraph, {{ABSTRACT_PUBMED_8846221}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 8846221 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_8846221}}


==About this Structure==
==About this Structure==
Line 27: Line 31:
[[Category: 1843u89]]
[[Category: 1843u89]]
[[Category: Dump]]
[[Category: Dump]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May  3 10:18:39 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 00:15:53 2008''